10.19.26 -- Reprogramming Cancer And Competing With China With Earli's Cyriac Roeding

Advanced AAV analytics use high‑resolution multiplex platforms to assess genome integrity and capsid traits, improving accuracy, speeding development, and supporting regulatory quality control.

Learn how eSource-ready sites are improving trial efficiency, reducing site burden, and becoming essential to modern clinical trial execution.

Once used primarily by large sponsors and concentrated in specific areas, functional service providers (FSPs) have evolved alongside the growing complexity and costs of clinical research.

Outlined here are the inherent benefits of PFS and how they relate to the delivery of drugs, such as biologics and vaccines, how SARS-CoV-2 could be fueling an explosive increase in PFS demand, and how a partnership with a flexible CDMO is the key to success.

Join us to see how HEOR drives impact across the global healthcare landscape.

Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.